Sign in

CIK 0001829802 · <br>Emerging growth company

Faeth Therapeutics, Inc.

Sign in to watch
Ticker
FTH
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
Phone
512-200-2982
Business address
701 TILLERY STREET #12 #1010, AUSTIN, TX, 78702
Former names
Sensei Biotherapeutics, Inc.
  1. 4 Grant or award Director acquired 4,466 shares (grant or award)
  2. 4 Grant or award Director acquired 4,466 shares (grant or award)
  3. 4 Grant or award Director acquired 4,466 shares (grant or award)
  4. 4 Grant or award Director acquired 4,466 shares (grant or award)
  5. 4 Grant or award Director acquired 4,466 shares (grant or award)
  6. 4 Grant or award 10% owner acquired 4,466 shares (grant or award)
  7. 4 Open-market sale 10% owner sold 3,441,661 shares at $1.58 ($5,437,824)
  8. 4/A Grant or award Chief Financial Officer acquired 51,346 shares (grant or award)
  9. 4/A Grant or award President and CEO acquired 73,193 shares (grant or award)
  10. 4/A Grant or award Chief Business Officer acquired 43,513 shares (grant or award)
  11. 4/A Grant or award 10% owner acquired 4,466 shares (grant or award)
  12. 4 Open-market buy 10% owner bought 2,200 shares at an average $1.61 ($3,539)
  13. 4 Grant or award Chief Scientific Officer acquired 41,265 shares (grant or award)
  14. 4 Grant or award Chief Business Officer acquired 43,513 shares (grant or award)
  15. 4 Grant or award Chief Financial Officer acquired 51,346 shares (grant or award)
  16. 4 Grant or award President and CEO acquired 73,193 shares (grant or award)
  17. 3 Insider Initial Statement of Ownership
  18. 4/A Insider Changes in Ownership
  19. 4/A Grant or award Director acquired 4,466 shares (grant or award)
  20. 3/A Insider 3/A

Page 5 of 13 · 245 filings